Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling
Yıl: 2021 Cilt: 30 Sayı: 1 Sayfa Aralığı: 36 - 41 Metin Dili: İngilizce DOI: 10.5336/ophthal.2020-76638 İndeks Tarihi: 31-08-2021
Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling
Öz: Objective: To report whether adjunctive intravitreal (IV) triamcinolone acetonide (TA) (2 mg/0.05 mL) injection provided bet-ter anatomical and functional outcomes in patients having undergone pars plana vitrectomy (PPV) for idiopathic epiretinal membrane (ERM) peeling. Material and Methods: A total of 27 eyes of 27 patients with idiopathic ERM were enrolled in and were divided into 2 groups based on having injection of 2 mg/0.05 ml IV TA at the end of the surgery as TA (-) and TA (+) group. ERM was stained with brilliant blue. Mean change in best-corrected visual acuity (BCVA), central macular thick-ness (CMT) and intraocular pressure (IOP) from baseline was evalua-ted at postoperative visits over 6-month follow-up. Results: The mean BCVA improved from 0.35±0.16 logMAR (range: 0.15-0.7) and 0.48±0.30 logMAR (range: 0.15-1.30) at baseline to 0.20±0.16 (range:0.05-0.5) and 0.34±0.23 logMAR (range: 0.1-1) at postop 6-month in TA (+) group (p=0.020) and TA (-) group (p=0.014), respectively. There was no significant difference in mean BCVA and CMT change at any follow-up visits between the 2 groups (p>0.05 for all visits) . IOP re-mained stable in both groups during follow-up. Conclusion: IV injec-tion of TA did not seem to provide additional benefit for post-operative anatomical and functional outcomes.
Anahtar Kelime: Epiretinal Membran Soyulması İçin Yapılan Vitrektomide Yardımcı İntravitreal Triamsinolon Asetonid Enjeksiyonunun Kısa Dönem Etkinliği
Öz: Amaç: İdiyopatik epiretinal membran (ERM) soyulması amacıyla pars plana vitrektomi (PPV) uygulanan hastalarda yardımcı intravitreal (IV) triamsinolon asetonid (TA) (2 mg/0.05 mL) enjek-siyonunun daha iyi anatomik ve fonksiyonel sonuçlar sa ğlayıp sağlamadı ğın ı belirlemek. Gereç ve Yöntemler: İdiyopatik ERM tanısı alan 27 hastanın toplam 27 gözü dâhil edildi. Hastalar, ameliyat sonunda IV TA (2 mg/0,05) uygulanıp uygulanmamasına göre TA(-) ve TA(+) olarak 2 gruba ayrıldı. ERM boyanmas ı için brilliant mavisi kullanı ldı. Olguların en iyi düzeltilmiş görme keskinliği (EİDGK), santral makula kalınlı ğı (SMK) ve göz içi basıncı (GİB)ndaki orta-lama değişim, 6 aylık takipleri süresince değ erlendirildi. Bulgular: TA (+) grubunda preoperatif olarak, LogMAR eşeline göre 0,35±0,16 (aralık: 0,15- 0,7) olan E İDGK postoperatif 6. ayda 0,20±0,16 (aralık: 0,05-0,5) idi (p=0,020). TA (-) grubunda ortalama EDGK preoperatif 0,48±0,30 (aralık: 0,15-1,30) iken postoperatif 6. ayda 0,34±0,23 (aralı k: 0,1-1) idi (p=0,014). İki grup arasında takip vizitlerinde orta-lama E İDGK ve SMK değişimi açısından anlamlı fark yoktu (tüm vizitler için p>0,05). Takipler sırasında GİB değerleri her 2 grupta da değişim göstermedi. Sonuç: IV TA enjeksiyonu ameliyat sonrası anatomik ve fonksiyonel sonuçlar için ek bir fayda sağlamıyor gibi gözükmektedir.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology. 1997;104(6):1033-40.[Crossref] [PubMed]
- 2. Kawasaki R, Wang JJ, Mitchell P, Aung T, Saw SM, Wong TY; Singapore Malay Eye Study Group. Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians. Br J Ophthalmol. 2008;92(10): 1320-4. [Crossref] [PubMed]
- 3. Gaber R, You QS, Muftuoglu IK, Alam M, Tsai FF, Mendoza N, et al. Characteristics of epiretinal membrane remnant edge by optical coherence tomography after pars plana vit-rectomy. Retina. 2017;37(11):2078-83.[Cross-ref] [PubMed] [PMC]
- 4. Muftuoglu IK, Lin T, Nudleman E, Gaber R, Bartsch DU, Freeman WR, et al. Identification of factors related to subfoveal detachment secondary to epiretinal membrane. Retina. 2019;39(5):988-98.[Crossref] [PubMed]
- 5. Akıncıoğlu D, Özge G, Küçükevcilioğlu M, Er-durman FC, Durukan AH. Surgical outcomes of idiopathic epiretinal membrane: the Gül-hane experience. Turk J Ophthalmol. 2018; 48(2):75-80.[Crossref] [PubMed] [PMC]
- 6. Horozoglu F, Yanyalı A, Çelik E, Nohutçu AF. [Internal limiting membrane removal in macu-lar epiretinal membranes]. Journal of Retina-Vitreus. 2005;13(2):99-102.[Link]
- 7. Muftuoglu IK, Tsai FF, Lin T, Freeman WR. High-dose decanted triamcinolone for treat-ment-resistant persistent macular edema. Ophthalmic Surg Lasers Imaging Retina. 2017;1;48(9):717-26.[Crossref] [PubMed]
- 8. Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A, et al. Müller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol. 2007;245(5):627-36.[Crossref] [PubMed]
- 9. Zhang X, Bao S, Lai D, Rapkins RW, Gillies MC. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its recep-tors in early diabetic rat retinas. Diabetes. 2008;57(4):1026-33. Erratum in: Diabetes. 2010;59(3):756.[Crossref] [PubMed] [PMC]
- 10. Pesin SR, Olk RJ, Grand MG, Boniuk I, Ar-ribas NP, Thomas MA, et al. Vitrectomy for premacular fibroplasia. Prognostic factors, long-term follow-up, and time course of visual improvement. Ophthalmology. 1991;98(7): 1109-14. [Crossref] [PubMed]
- 11. Hattenbach LO, Springer-Wanner C, Hoerauf H, Callizo J, Jungmann S, Brauns T, et al. In-travitreal sustained-release steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica. 2017;237(4):232-7.[Cross-ref] [PubMed]
- 12. Sella R, Gal-or O, Goh YW, Ahmad N, Polk-inghorne P, Ehrlich R, et al. Role of concomi-tant triamcinolone acetonide injection in small-gauge vitrectomy for idiopathic epireti-nal membrane peel. Asia Pac J Ophthalmol (Phila). 2015;4(4):204-7.[Crossref] [PubMed]
- 13. Angermann R, Zehetner C, Sidoroff P, Waltl I, Kieselbach G, Kralinger M, et al. Triamci-nolone in small-gauge vitrectomy for epireti-nal membrane peeling. Can J Ophthalmol. 2018;53(6):632-6.[Crossref] [PubMed]
- 14. Hamoudi H, Correll Christensen U, La Cour M. Epiretinal membrane surgery: an analysis of 2-step sequential- or combined phacovit-rectomy surgery on refraction and macular anatomy in a prospective trial. Acta Ophthal-mol. 2018;96(3):243-50.[Crossref] [PubMed]
- 15. Chen SJ, Tsai FY, Liu HC, Chung YC, Lin TC. Postoperative inner nuclear layer microcysts affecting long-term visual outcomes after epiretinal membrane surgery. Retina. 2016;36(12):2377-83.[Crossref] [PubMed]
- 16. Zur D, Iglicki M, Feldinger L, Schwartz S, Goldstein M, Loewenstein A, et al. Disorgani-zation of Retinal Inner Layers as a Biomarker for Idiopathic Epiretinal Membrane After Mac-ular Surgery-The DREAM Study. Am J Oph-thalmol. 2018;196:129-35.[Crossref] [PubMed]
- 17. Oster SF, Mojana F, Brar M, Yuson RM, Cheng L, Freeman WR, et al. Disruption of the photoreceptor inner segment/outer segment layer on spectral domain-optical coherence to-mography is a predictor of poor visual acuity in patients with epiretinal membranes. Retina. 2010;30(5):713-8.[Crossref] [PubMed]
- 18. Paspulati A, Punjabi OS, Theodoropoulou S, Singh RP. Triamcinolone acetonide as an ad-juvant to membrane peeling surgery: a pilot study. Ophthalmic Surg Lasers Imaging Retina. 2013;44(1):41-5.[Crossref] [PubMed]
- 19. Ahn JH, Park HJ, Lee JE, Oum BS. Effect of intravitreal triamcinolone injection during vit-rectomy for idiopathic epiretinal membrane. Retina. 2012;32(5):892-6.[Crossref] [PubMed]
| APA | James B, KILIC MUFTUOGLU I, Karabaş L (2021). Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. , 36 - 41. 10.5336/ophthal.2020-76638 |
| Chicago | James Braydon,KILIC MUFTUOGLU ILKAY,Karabaş Levent Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. (2021): 36 - 41. 10.5336/ophthal.2020-76638 |
| MLA | James Braydon,KILIC MUFTUOGLU ILKAY,Karabaş Levent Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. , 2021, ss.36 - 41. 10.5336/ophthal.2020-76638 |
| AMA | James B,KILIC MUFTUOGLU I,Karabaş L Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. . 2021; 36 - 41. 10.5336/ophthal.2020-76638 |
| Vancouver | James B,KILIC MUFTUOGLU I,Karabaş L Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. . 2021; 36 - 41. 10.5336/ophthal.2020-76638 |
| IEEE | James B,KILIC MUFTUOGLU I,Karabaş L "Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling." , ss.36 - 41, 2021. 10.5336/ophthal.2020-76638 |
| ISNAD | James, Braydon vd. "Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling". (2021), 36-41. https://doi.org/10.5336/ophthal.2020-76638 |
| APA | James B, KILIC MUFTUOGLU I, Karabaş L (2021). Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. Türkiye Klinikleri Oftalmoloji Dergisi, 30(1), 36 - 41. 10.5336/ophthal.2020-76638 |
| Chicago | James Braydon,KILIC MUFTUOGLU ILKAY,Karabaş Levent Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. Türkiye Klinikleri Oftalmoloji Dergisi 30, no.1 (2021): 36 - 41. 10.5336/ophthal.2020-76638 |
| MLA | James Braydon,KILIC MUFTUOGLU ILKAY,Karabaş Levent Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. Türkiye Klinikleri Oftalmoloji Dergisi, vol.30, no.1, 2021, ss.36 - 41. 10.5336/ophthal.2020-76638 |
| AMA | James B,KILIC MUFTUOGLU I,Karabaş L Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. Türkiye Klinikleri Oftalmoloji Dergisi. 2021; 30(1): 36 - 41. 10.5336/ophthal.2020-76638 |
| Vancouver | James B,KILIC MUFTUOGLU I,Karabaş L Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling. Türkiye Klinikleri Oftalmoloji Dergisi. 2021; 30(1): 36 - 41. 10.5336/ophthal.2020-76638 |
| IEEE | James B,KILIC MUFTUOGLU I,Karabaş L "Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling." Türkiye Klinikleri Oftalmoloji Dergisi, 30, ss.36 - 41, 2021. 10.5336/ophthal.2020-76638 |
| ISNAD | James, Braydon vd. "Short Term Efficacy of Adjunctive Intravitreal Triamcinolone Acetonide Injection During Vitrectomy for Epiretinal Membrane Peeling". Türkiye Klinikleri Oftalmoloji Dergisi 30/1 (2021), 36-41. https://doi.org/10.5336/ophthal.2020-76638 |
